LocationClientCostCompletion Cambridge, UK AstraZeneca £1b 2023Project details We are lead consultant for AstraZeneca’s new Discovery Centre (DISC), a state-of-the-art global R&D facility. We are also responsible for the executive architecture, combined engineering, landscape, interiors, ...
AstraZeneca has established a new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge Biomedical Campus (CBC). The CBC plays an important role in the UK and Europe’s leading life sciences cluster. It is a hub...
Completed in 2021 in Cambridge, United Kingdom. Images by Hufton+Crow. AstraZeneca is establishing a new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge...
The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn ...
British-Swedish pharmaceutical and biologics company AstraZeneca built a global research and development (R&D) facility, named the Discovery Centre (DISC), at the Cambridge Biomedical Campus (CBC) in Cambridge, UK. The state-of-the-art facility serves as the hub for AstraZeneca’s R&D activities...
AstraZeneca's Discovery Centre by Herzog de Meuron is inaugurated in Cambridge, a new research and development hub with a suitably advanced design
The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial ...
The Discovery Centre (DISC) in Cambridge, United Kingdom, will include advanced robotics, high-throughput screening, and artificial intelligence-driven technology. In total, the facility will accommodate over 2,200 research scientists. Then in March 2022, AstraZeneca launched ...
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabo...
AstraZenecanews release. Available at:https://www.astrazeneca.com/media-centre/press-releases/2019/fasenra-approved-in-the-us-for-self-administration-in-a-new-pre-filled-auto-injector-the-fasenra-pen-04102019.html. [Last accessed:April 2024]. ...